Q7SSI0 (Q7SSI0_9HIV1) Human immunodeficiency virus 1

Protease UniProtKBInterProInteractive Modelling

99 aa; Sequence (Fasta)

Available Structures

25 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease… Heteromer
P04587;
1-99
SO4;DMS;MK1;ACY;GOL;
Assess
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir Heteromer
Q7SSE3;
1-99
478; 17×IOD;GOL;
Assess
HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI Heteromer
P04587;
1-99
NA;CL;GOL;
Assess
HIV-1 protease mutant I54V complexed with gem-diol-amine intermediate NLLTQI Heteromer
P04587;
1-99
NA;CL;
Assess
Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir)…homo-2-mer1-99
CL;017;DMS;
Assess
Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavirhomo-2-mer1-99
SO4;ROC;
Assess
Crystal structure analysis of HIV-1 protease mutant V82A with a potent non-peptide inhibitor (UIC-9…homo-2-mer1-99
CL;PO4;DMS;ACY;GOL;017;
Assess
Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavirhomo-2-mer1-99
CL;NA;SO4;ROC;
Assess
Wild Type HIV-1 Protease with Antiviral Drug Saquinavirhomo-2-mer1-99
ROC;FMT;SO4;
Assess
Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavirhomo-2-mer1-99
ROC;ACY;GOL;SO4;
Assess
Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir)homo-2-mer1-99
CL;017;DMS;
Assess
Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavirhomo-2-mer1-99
NA;CL;ROC;ACY;GOL;
Assess
Crystal structure of wild-type HIV-1 protease with novel tricyclic P2-ligands GRL-0739Ahomo-2-mer1-99
G79;CL;ACT;NA;GOL;
Assess
Structure of Unliganded HIV-1 Protease F53L Mutanthomo-2-mer1-99
Assess
Wild-type HIV-1 Protease in complex with potent inhibitor GRL06579homo-2-mer1-99
CL;NA;GRL;GOL;
Assess
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212homo-2-mer1-99
NA;CL;017;GOL;ACT;
Assess
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121homo-2-mer1-99
017;PO4; 10×IOD;
Assess
HIV-1 protease with TMC-126homo-2-mer1-99
DJR;
Assess
HIV-1 protease triple mutants V32I, I47V, V82I with GRL-011-11A (a methylamine bis-Tetrahydrofuran …homo-2-mer1-99
FMT;4UY;GOL;
Assess
Crystal structure analysis of HIV-1 protease mutant I84V with a potent non-peptide inhibitor (UIC-9…homo-2-mer1-99
CL;NA;017;
Assess
Room temperature X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral …homo-2-mer1-99
P3V;
Assess
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavirhomo-2-mer1-99
ROC;ACT;
Assess
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at p…homo-2-mer1-99
478;
Assess
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH…homo-2-mer1-99
017;
Assess
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral int…homo-2-mer1-99
KVS;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1aid.1.Ahomo-2-mer0.831-99
THK;93.94
Assess